The Pachychoroid Disease Spectrum-and the Need for a Uniform Classification System

被引：77
作者：
Siedlecki, Jakob [1 ,2 ,3 ,4 ,5 ,6 ]
Schworm, Benedikt [3 ,7 ]
Priglinger, Siegfried G. [3 ,6 ,8 ,9 ,10 ]
机构：
[1] Bayer AG, Munich, Germany
[2] Roche AG, Munich, Germany
[3] Novartis Pharma GmbH, Munich, Germany
[4] Carl Zeiss Meditec AG, Munich, Germany
[5] Oculentis OSD Med GmbH, Munich, Germany
[6] Pharm Allergan GmbH, Munich, Germany
[7] Topcon Corp, Munich, Germany
[8] Bayer AG, Munich, Germany
[9] Alcon Pharma GmbH, Munich, Germany
[10] Oertli AG, Munich, Germany
来源：
OPHTHALMOLOGY RETINA | 2019年 / 3卷 / 12期
关键词：
D O I：
10.1016/j.oret.2019.08.002
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1013 / 1015
页数：3
相关论文
共 16 条
[1]   Examining the Choroid in Ocular Inflammation: A Focus on Enhanced Depth Imaging [J].
Baltmr, Abeir ;
Lightman, Sue ;
Tomkins-Netzer, Oren .
JOURNAL OF OPHTHALMOLOGY, 2014, 2014
[2]   Pachychoroid disease [J].
Cheung, Chui Ming Gemmy ;
Lee, Won Ki ;
Koizumi, Hideki ;
Dansingani, Kunal ;
Lai, Timothy Y. Y. ;
Freund, K. Bailey .
EYE, 2019, 33 (01) :14-33
[3]   Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Pachychoroid Neovasculopathy [J].
Cho, Han Joo ;
Jung, Seong Heon ;
Cho, Suyeon ;
Han, Jae Ook ;
Park, Saemi ;
Kim, Jong Woo .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 35 (03) :174-181
[4]   Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of "expanded spectra' - a review [J].
Dansingani, Kunal K. ;
Gal-Or, Orly ;
Sadda, Srinivas R. ;
Yannuzzi, Lawrence A. ;
Freund, K. Bailey .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 46 (02) :189-200
[5]   EN FACE IMAGING OF PACHYCHOROID SPECTRUM DISORDERS WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY [J].
Dansingani, Kunal K. ;
Balaratnasingam, Chandrakumar ;
Naysan, Jonathan ;
Freund, K. Bailey .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (03) :499-516
[6]   Pachychoroid pigment epitheliopathy in fellow eyes of patients with unilateral central serous chorioretinopathy [J].
Ersoz, M. Giray ;
Karacorlu, Murat ;
Arf, Serra ;
Hocaoglu, Mumin ;
Sayman Muslubas, Isil .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2018, 102 (04) :473-478
[7]   TYPE 1 (SUB-RETINAL PIGMENT EPITHELIAL) NEOVASCULARIZATION IN CENTRAL SEROUS CHORIORETINOPATHY MASQUERADING AS NEOVASCULAR AGE-RELATED MACULAR DEGENERATION [J].
Fung, Adrian T. ;
Yannuzzi, Lawrence A. ;
Freund, K. Bailey .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (09) :1829-1837
[8]   Diagnostic and therapeutic challenges [J].
Jampol, Lee M. ;
Shankle, Jonathan ;
Schroeder, Robert ;
Tornambe, Paul ;
Spaide, Richard F. ;
Hee, Michael R. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (09) :1072-1076
[9]   Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy [J].
Jung, Byung Ju ;
Kim, JooYoung ;
Lee, Jae Hyung ;
Baek, Jiwon ;
Lee, Kook ;
Lee, Won Ki .
SCIENTIFIC REPORTS, 2019, 9 (1)
[10]   Risk Factors and Outcomes of Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy [J].
Lee, Ga-In ;
Kim, A. Young ;
Kang, Se Woong ;
Cho, Soo Chang ;
Park, Kyu Hyung ;
Kim, Sang Jin ;
Kim, Kyung Tae .
SCIENTIFIC REPORTS, 2019, 9 (1)
12